Tanaka E - Search Results

1

The metabolism and excretion of trimethadione in patients with percutaneous transhepatic biliary drainage and renal dysfunction.

Tanaka E, Ishikawa A, Yamamoto Y, Fukao K, Iwasaki Y, Misawa S. Tanaka E, et al. J Pharmacobiodyn. 1989 Mar;12(3):145-8. doi: 10.1248/bpb1978.12.145. J Pharmacobiodyn. 1989. PMID: 2760794

2

Changes in caffeine, lidocaine and trimethadione metabolism in carbon tetrachloride-intoxicated rats as assessed by a "cocktail" study.

Tanaka E, Ishikawa A, Misawa S. Tanaka E, et al. Pharmacol Toxicol. 1994 Sep-Oct;75(3-4):150-3. doi: 10.1111/j.1600-0773.1994.tb00338.x. Pharmacol Toxicol. 1994. PMID: 7800655

3

Trimethadione metabolism as a probe drug to estimate hepatic oxidizing capacity in rats.

Tanaka E, Ishikawa A, Kobayashi S, Yasuhara H, Misawa S, Kuroiwa Y. Tanaka E, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Feb;104(2):205-7. doi: 10.1016/0742-8413(93)90025-g. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993. PMID: 8098675 Review.

4

Trimethadione tolerance tests for the assessment of feasible size of hepatic resection in patients with hepatocellular carcinoma.

Ishikawa A, Fukao K, Tsuji K, Osada A, Yamamoto Y, Ohtsuka M, Tanaka E. Ishikawa A, et al. Among authors: tanaka e. J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):426-32. doi: 10.1111/j.1440-1746.1993.tb01542.x. J Gastroenterol Hepatol. 1993. PMID: 8218989

5

Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.

Tanaka E, Ishikawa A, Yamamoto Y, Osada A, Tsuji K, Fukao K, Iwasaki Y. Tanaka E, et al. Pharmacol Toxicol. 1993 Jan;72(1):31-3. doi: 10.1111/j.1600-0773.1993.tb01335.x. Pharmacol Toxicol. 1993. PMID: 8441739

6

Influence of partial hepatectomy in dogs on trimethadione metabolism and microsomal monooxygenases.

Tanaka E, Osada A, Ishikawa A, Nakamura T, Momose Y, Mikami T, Fukao K, Horie T. Tanaka E, et al. Xenobiotica. 1995 Dec;25(12):1301-10. doi: 10.3109/00498259509061919. Xenobiotica. 1995. PMID: 8719906

7

Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans.

Tanaka E, Ishikawa A, Abei M, Kobayashi S. Tanaka E, et al. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996 Nov;115(3):211-6. doi: 10.1016/s0742-8413(96)00102-8. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1996. PMID: 9375358 Review.

8

Trimethadione metabolism in patients with normal liver and in patients with chronic liver disease.

Tanaka E, Ishikawa A, Ono A, Okamura T, Misawa S. Tanaka E, et al. J Pharmacobiodyn. 1987 Sep;10(9):499-502. doi: 10.1248/bpb1978.10.499. J Pharmacobiodyn. 1987. PMID: 2830397

9

Sex-related differences in hepatic drug-oxidizing capacity of streptozotocin-induced diabetic rats.

Tanaka E, Ishikawa A, Misawa S, Kuroiwa Y. Tanaka E, et al. J Pharmacobiodyn. 1988 Jun;11(6):416-23. doi: 10.1248/bpb1978.11.416. J Pharmacobiodyn. 1988. PMID: 3050023

10

Trimethadione tolerance test for evaluation of functional reserve of the liver in patients with liver cirrhosis and esophageal varices.

Tanaka E, Ishikawa A, Ono A, Okamura T, Kobayashi S, Yasuhara H, Misawa S. Tanaka E, et al. J Pharmacobiodyn. 1986 Mar;9(3):297-302. doi: 10.1248/bpb1978.9.297. J Pharmacobiodyn. 1986. PMID: 3723321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,382 results

Search Page

Filters